Fieldmesh store-and-forward integrity testing
Timestamp and ordering integrity across simulated outages of up to 90 days.
The studies and reports behind our devices, including the ones still running. Each entry says what kind of evidence it is, because a bench test and a clinical trial are not the same claim.
| Product | Study | Design | Size | Status |
|---|---|---|---|---|
| Axon Sense 3 | Human factors and wear study | Prospective, single arm, 28 days | 140 participants | Enrolling since Aug 2026 |
| Axon Sense 2 | Post-discharge heart failure monitoring at Great Lakes Health | Prospective cohort with historical comparison | About 900 patients | Follow-up through 2027 |
| Axon Sense 2 | Rhythm detection agreement with Holter monitoring | Prospective, paired recordings | 212 participants | Peer-reviewed, 2024 |
| Corta | Diagnostic yield in unexplained syncope | Prospective, multicenter | 384 patients | Peer-reviewed, 2025 |
| Axon Sense 2 and Lattice Bench | Home versus laboratory pediatric sleep measures | Paired validation, then home cohort | 20 plus 68 children | Validation published; cohort ongoing |
| Nexa Edge Vehicle | Prehospital ECG transmission in a rural EMS service | Retrospective service evaluation | 212 transmissions | Conference abstract, 2026 |
Testing we did ourselves or commissioned. Available to customers on request.
Eleven weeks, 68 units, battery, thermal, ingress and data integrity.
Assessment against IEC 62304 for Class C software. Under NDA.
74 sites, 214 excursions, all explained.
Timestamp and ordering integrity across simulated outages of up to 90 days.
Coexistence testing of Axon Sense and Nexa Edge alongside common bedside equipment.
Customers and evaluating organizations can request any report listed here. Peer-reviewed papers are cited in full in the request response.